206 filings
6-K
ENLV
Enlivex Therapeutics Ltd
29 Apr 24
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
8:01am
6-K
ENLV
Enlivex Therapeutics Ltd
22 Apr 24
Report of Foreign Private Issuer
8:02am
6-K
ENLV
Enlivex Therapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
8:00am
6-K
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
6-K
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
bmc7vjki1km19
7 Feb 24
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
8:02am
6-K
uhmn1
22 Jan 24
Report of Foreign Private Issuer
8:00am
6-K
jn808m9vko8n1pz
17 Jan 24
Report of Foreign Private Issuer
8:02am
6-K
wjam1609dg 1g1
20 Dec 23
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
8:01am
6-K
jjghqg9f371lmivc4
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
amg2ohuto6 zd
7 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
p9b1oa39eh73l523ba
2 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
zhi3z9b92q3yh61k2
26 Oct 23
Report of Foreign Private Issuer
4:30pm
6-K
3r3r3ugu2h0x
18 Sep 23
Report of Foreign Private Issuer
8:00am
6-K
1riiell19hrp00a5xvf
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
4y5wbwdg
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
6-K
oji hnxiz69
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
qzexksc8 kxc
2 Aug 23
Report of Foreign Private Issuer
8:05am
6-K
m6s kdrs5nao31z4lel
31 Jul 23
Enlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis
8:05am
6-K
ilz127 9bess
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am